Profound Medical Capital Surpluse Over Time
| PROF Stock | USD 8.12 0.03 0.37% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Profound Medical Performance and Profound Medical Correlation. Profound |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.34) | Revenue Per Share 0.38 | Quarterly Revenue Growth 0.639 | Return On Assets (0.45) | Return On Equity (0.90) |
The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Capital Surpluse Analysis
Compare Profound Medical Corp and related stocks such as Si Bone, Sight Sciences, and Nevro Corp Capital Surpluse Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SIBN | 6.1 M | 6.1 M | 6.1 M | 6.1 M | 6.1 M | 6.1 M | 8 M | 9.9 M | 246.9 M | 258.1 M | 408.1 M | 455.2 M | 455.2 M | 523.4 M | 549.6 M |
| SGHT | 385.1 M | 385.1 M | 385.1 M | 385.1 M | 385.1 M | 385.1 M | 385.1 M | 385.1 M | 385.1 M | 385.1 M | 385.1 M | 385.1 M | 399.3 M | 459.2 M | 431.4 M |
| NVRO | 293.9 M | 293.9 M | 293.9 M | 293.9 M | 293.9 M | 424.1 M | 470.9 M | 508.2 M | 552.6 M | 626.4 M | 880.7 M | 928.1 M | 934.1 M | 1.1 B | 686.8 M |
| FNA | 17.1 M | 17.1 M | 17.1 M | 17.1 M | 17.1 M | 17.1 M | 17.1 M | 17.1 M | 17.1 M | 17.1 M | 22.5 M | 197.9 M | 214 M | 246 M | 124.1 M |
| LUNG | 467.1 M | 467.1 M | 467.1 M | 467.1 M | 467.1 M | 467.1 M | 467.1 M | 467.1 M | 467.1 M | 467.1 M | 467.1 M | 482.9 M | 502.7 M | 578.1 M | 532.7 M |
| IRMD | 15.8 M | 15.8 M | 15.8 M | 15.8 M | 15.8 M | 19.3 M | 12.1 M | 12.6 M | 15.3 M | 19.2 M | 23.7 M | 25.2 M | 26.4 M | 30.4 M | 20.7 M |
| OFIX | 214.3 M | 214.3 M | 246.3 M | 232.8 M | 232.8 M | 232.1 M | 204.1 M | 220.6 M | 243.2 M | 271 M | 292.3 M | 314 M | 335 M | 385.2 M | 280.6 M |
| NPCE | 497.5 M | 497.5 M | 497.5 M | 497.5 M | 497.5 M | 497.5 M | 497.5 M | 497.5 M | 497.5 M | 497.5 M | 497.5 M | 497.5 M | 506.7 M | 582.7 M | 552.3 M |
| ITGR | 307.2 M | 307.2 M | 320.6 M | 344.9 M | 366.1 M | 620.5 M | 638 M | 669.8 M | 691.1 M | 701 M | 700.8 M | 713.1 M | 731.4 M | 841.1 M | 623.7 M |
| LIVN | 1.7 B | 1.7 B | 1.7 B | 1.7 B | 1.7 B | 1.7 B | 1.7 B | 1.7 B | 1.7 B | 1.7 B | 1.8 B | 2.1 B | 2.1 B | 2.4 B | 2 B |
| ELMD | 13 M | 13 M | 13.1 M | 13.2 M | 13.3 M | 13.5 M | 14 M | 15 M | 16.1 M | 16.5 M | 17.4 M | 18.3 M | 18.8 M | 21.6 M | 16.7 M |
| KIDS | 17.4 M | 17.4 M | 17.4 M | 17.4 M | 17.4 M | 17.4 M | 12.8 M | 150.4 M | 197.4 M | 271.2 M | 388.6 M | 394.9 M | 560.8 M | 644.9 M | 677.2 M |
| SRDX | 74.5 M | 18.3 M | 2 M | 3.1 M | 3.1 M | 6.8 M | 5.4 M | 7.6 M | 10.7 M | 15.4 M | 21.6 M | 28.8 M | 28.8 M | 25.9 M | 14.1 M |
| CVRX | 540.7 M | 540.7 M | 540.7 M | 540.7 M | 540.7 M | 540.7 M | 540.7 M | 540.7 M | 540.7 M | 540.7 M | 540.7 M | 540.7 M | 545.4 M | 627.2 M | 597.3 M |
| AORT | 322.9 M | 322.9 M | 322.9 M | 322.9 M | 322.9 M | 322.9 M | 322.9 M | 322.9 M | 322.9 M | 322.9 M | 322.9 M | 322.9 M | 337.4 M | 388 M | 363.1 M |
Profound Medical Corp and related stocks such as Si Bone, Sight Sciences, and Nevro Corp Capital Surpluse description
My Equities
My Current Equities and Potential Positions
| Profound Medical Corp | PROF |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Ontario; Canada |
| Exchange | NASDAQ Exchange |
USD 8.12
Check out Profound Medical Performance and Profound Medical Correlation. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Profound Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.